Literature DB >> 21227647

Tissue-Doppler assessment of cardiac left ventricular function during short-term adjuvant epirubicin therapy for breast cancer.

Jon M Appel1, Peter Sogaard, Christiane E Mortensen, Knud Skagen, Dorte L Nielsen.   

Abstract

BACKGROUND: It has been hypothesized that the extent of acute anthracycline-induced cardiotoxicity reflects the risk for late development of heart failure. The aim of this study was to examine if short-term changes in cardiac function can be detected even after low-dose adjuvant epirubicin therapy for breast cancer when using Doppler tissue imaging of longitudinal left ventricular function.
METHODS: Eighty consecutive women in good cardiopulmonary health scheduled to undergo adjuvant treatment for breast cancer were included. They were examined using echocardiography and Doppler tissue imaging before and after three treatment series of epirubicin (mean cumulative dose, 273.7 ± 46.6 mg/m(2); median time interval, 9 weeks; range, 47-113 days).
RESULTS: Apart from a marginal reduction in E/A ratio, none of the conventional Doppler echocardiographic or Doppler tissue imaging indices of systolic and diastolic function were affected during epirubicin treatment.
CONCLUSIONS: In contrast to several previous studies using tissue Doppler and conventional echocardiography, this study did not document relevant short-term effects of low-dose epirubicin treatment on heart function.
Copyright © 2011 American Society of Echocardiography. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21227647     DOI: 10.1016/j.echo.2010.12.004

Source DB:  PubMed          Journal:  J Am Soc Echocardiogr        ISSN: 0894-7317            Impact factor:   5.251


  5 in total

Review 1.  Cancer and cardiovascular disease: the use of novel echocardiography measures to predict subsequent cardiotoxicity in breast cancer treated with anthracyclines and trastuzumab.

Authors:  Gaurav Gulati; Kathleen W Zhang; Marielle Scherrer-Crosbie; Bonnie Ky
Journal:  Curr Heart Fail Rep       Date:  2014-12

2.  Relationship of promising methods in the detection of anthracycline-induced cardiotoxicity in breast cancer patients.

Authors:  Ben F Bulten; Hein J Verberne; Louise Bellersen; Wim J G Oyen; Aida Sabaté-Llobera; Annelies M C Mavinkurve-Groothuis; Livia Kapusta; Hanneke W M van Laarhoven; Lioe-Fee de Geus-Oei
Journal:  Cancer Chemother Pharmacol       Date:  2015-09-23       Impact factor: 3.333

3.  Two-dimensional strain echocardiography for detection of cardiotoxicity in breast cancer patients undergoing chemotherapy.

Authors:  Mehrnoush Toufan; Leili Pourafkari; Leila Ghahremani Nasab; Ali Esfahani; Zohreh Sanaat; Alireza Nikanfar; Nader D Nader
Journal:  J Cardiovasc Thorac Res       Date:  2017-03-13

4.  Preventing effect of astragalus polysaccharide on cardiotoxicity induced by chemotherapy of epirubicin: A pilot study.

Authors:  Xiaofang Li; Xin Guo; Jun Li; Li Yuan; Haixiong Wang
Journal:  Medicine (Baltimore)       Date:  2022-08-12       Impact factor: 1.817

Review 5.  Multimodality Imaging in Cardiooncology.

Authors:  Fausto Pizzino; Giampiero Vizzari; Rubina Qamar; Charles Bomzer; Scipione Carerj; Concetta Zito; Bijoy K Khandheria
Journal:  J Oncol       Date:  2015-08-02       Impact factor: 4.375

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.